REGISTER now for FREE 
|
FREE patent keyword monitoring and additional FREE benefits. REGISTER now for FREE
|
|
|
Drug, Bio-affecting And Body Treating Compositions > Designated Organic Active Ingredient Containing (doai) > Heterocyclic Carbon Compounds Containing A Hetero Ring Having Chalcogen (i.e., O,s,se Or Te) Or Nitrogen As The Only Ring Hetero Atoms Doai > Five-membered Hetero Ring Containing At Least One Nitrogen Ring Atom (e.g., 1,2,3-triazoles, Etc.) > Tetrazoles (including Hydrogenated) > Imidazoles ImidazolesImidazoles patent applications listed are from June 2005 to current and include Date, Patent Application Number, Patent Title, Patent Abstract summary and are linked to the corresponding patent application page.11/30/06 - 20060270726 - Phenyl substituted cyclic derivatives Certain novel phenyl substituted cyclic derivatives have unexpected insecticidal activity. These compounds are represented by formula I: where B is a cyclic bridging group containing at least one N or N oxide link and a, A, b, B, c, d, D, L, M, R1 through R9, inclusively, and R13, R14 ... 09/21/06 - 20060211753 - Method and composition which reduces stimulation of muscles which dilate the eye A method for optimizing pupil size in individuals suffering from excessive pupillary dilation in dim light as well as through medication is disclosed. Alpha 1 antagonist is applied in an eye drop formulation to the eye, resulting in reduced pupil size in dim light, but less reduction in pupil size ... 08/24/06 - 20060189673 - Phenylazole compound, production process therefor and antioxidant (wherein R5 and R6 each independently represents a hydrogen atom, a cyano group, a hydroxyl group, a halogen atom, a C1-6 alkyl group, a C1-6 alkoxy group, or the like, k represents 0 or an integer of 1 to 15, and R5 and R6 may be identical or different from ... 08/10/06 - 20060178417 - Imidazol derivatives having affinity for alpha 2 receptors activity or pharmaceutically acceptable salts or hydrates thereof, wherein R represents unsubstituted or substituted lower alkyl, unsubstituted or substituted aryl, unsubstituted or substituted cycloalkyl, unsubstituted or substituted heteroaryl, unsubstituted or substituted lower alkylamino or a saturated five or six membered heterocyclic group containing one or two nitrogen atoms. ... 07/06/06 - 20060148875 - Agent for prophylaxis and treatment of diabetic complications The present invention relates to an agent for the prophylaxis and treatment of diabetic complications comprising, as an active ingredient, 4-[α-hydroxy-2-methyl-5-(1-imidazolyl)benzyl]-3,5-dimethylbenzoic acid, an optically active compound thereof or a pharmaceutically acceptable salt thereof. The present invention further relates to a method for the prophylaxis and treatment of diabetic complications comprising ... 07/06/06 - 20060148874 - Compounds for use in the treatment of aids and other viral diseases and hiv-related infections and compositions containing such compounds, methods of treating such diseases and infections and methods of making such compounds and compositions or salts or hydrates thereof in a carrier which minimizes micellar formation or van der Waals attraction of molecules of said compound. The invention also provides S enantiomeric forms of such compounds which possess the ability to inhibit cell growth whilst being of low toxicity to such cells and methods ... 06/29/06 - 20060142366 - Novel heteroaryl-substituted acetone derivatives as inhibitors of phospholipase a2 The invention relates to novel heteroaryl substituted acetone derivatives which inhibit the enzyme phospholipase A2, pharmaceutical preparations containing these compounds and a method of producing these compounds. ... 06/22/06 - 20060135585 - Compounds and methods for thiol-containing compound efflux and cancer treatment Methods for therapy of cystic fibrosis and other conditions such as cancer are provided. The methods comprise one or more agents capable of increasing thiol-containing compound transport via a transporter system (i.e. ABC transporters such as MDR-1 or MRP-2) in cells. Other embodiments include the use of agents to modulate ... 06/22/06 - 20060135584 - Novel imidazole alcohol compound, process for producing the same, and surface-treating agent comprising the same (In general formula (1), R1, R2 and R3 are each hydrogen, a vinyl group or an alkyl group with 1 to 20 carbon atoms, an aromatic ring may be formed by R2 and R3, X indicates hydrogen, an alkyl group with 1 to 6 carbon atoms, or a substituent group ... 03/30/06 - 20060069146 - Imidazole derivatives modulating the sodium channels wherein the substituents are defined as in the specification. ... 03/16/06 - 20060058365 - Compositions and methods for treatment of colitis The present invention relates to the treatment of inflammatory bowel disease (IBD) and related gastrointestinal pathologies. This invention also relates to the treatment of cytokine-mediated diseases, including tumor necrosis factor-α (TNFα)-induced diseases and/or chemokine-mediated diseases. This invention also relates to treating an animal having a disease or condition associated with ... 03/16/06 - 20060058364 - Treatment of dependence and dependence related withdrawal symptoms A method for treatment of dependence and dependence related withdrawal symptoms caused by the discontinuation of subacute or chronic use of psychostimulant agents, to ease a patient's withdrawal from the psychostimulants with an alpha2-adrenoceptor antagonist or a pharmaceutically acceptable ester or salt thereof. ... 03/09/06 - 20060052429 - Oromucosal formulation and process for preparing the same where Y is —CH2— or —CO—, R1 is halogen or hydroxy, R2 is H or halogen and R3 is H or lower alkyl, or an acid addition salt of this imidazole derivative, and a process for its preparation. ... 03/09/06 - 20060052428 - Neurological functions The present invention relates to materials and methods for treating neurological diseases and disorders including but not limited to epilepsy and autism, as well as general cognitive problems. ... 02/23/06 - 20060041001 - Novel imidazolic compounds, method for preparing same and use thereif as medicines wherein R1 is hydrogen, fluoro or methoxyl, R1 being in position 2, 3, 4 or 5 of the aromatic carbocycle; R2 is hydrogen or methyl; R3 is hydrogen, methyl or ethyl; and their pharmaceutically acceptable acid addition salts, hydrates of their pharmaceutically acceptable acid addition salts as well as the ... 02/02/06 - 20060025465 - Process for preparing substituted imidazole derivates and intermediates used in the process wherein Y, R1, R2 and R3 are as defined above. The invention also relates to intermediates and their preparation. ... 10/27/05 - 20050239856 - Method for prophylaxis and treatment of diabetic complications with 4{alpha-hydroxy-2-methyl-5-(1-imidazolyl)benzyl}-3,5-dimethylbenzoic acid and derivatives The present invention relates to an agent for the prophylaxis and treatment of diabetic complications comprising, as an active ingredient, 4-[α-hydroxy-2-methyl-5(1-imidazolyl)benzyl]-3,5-dimethylbenzoic acid, an optically active compound thereof or a pharmaceutically acceptable salt thereof. The present invention further relates to a method for the prophylaxis and treatment of diabetic complications comprising ... 09/08/05 - 20050197377 - Cck-1 receptor modulators Certain imidazole compounds are CCK1 modulators useful in the treatment of CCK1 mediated diseases. ... 08/25/05 - 20050187276 - Compounds, compositions and methods The present invention provides methods and pharmaceutical compositions for inhibiting expressions of HIF and HIF regulated genes, inhibiting angiogenesis, inducing cell cycle arrest in tumor cells, and treating cell proliferating diseases or conditions. ... 08/04/05 - 20050171176 - Pharmaceutically active aromatic guanylhydrazones The present invention relates to aromatic guanylhydrazone compounds and their use as pharmaceutically active agents, especially for prophylaxis and treatment of virally caused diseases and infections, including opportunistic infections. The inventive guanylhydrazone compounds are also useful as inhibitors of deoxyhypusine synthase and as inhibitors for nuclear export in infectious diseases ... 07/21/05 - 20050159470 - Histone deacetylase inhibitors wherein Z is a 5-membered aromatic heterocycle as shown herein, each X is independently selected from the group consisting of CR5 and N; each Y is independently selected from the group consisting of O, S and NR5; R1, R2, R3, R4 and R5 are as defined herein; Q is a ... 06/16/05 - 20050131043 - Phenylethynyl and styryl derivatives of imidazole and fused ring heterocycles wherein R6 to R26, X and Y are as defined in the specification or a pharmaceutically acceptable salt thereof, for use in pharmaceutical compositions for the treatment or prevention of mGluR5 receptor mediated disorders. ... ### FreshPatents.com Support |